Aprio Wealth Management LLC Makes New $272,000 Investment in Mettler-Toledo International, Inc. $MTD

Key Points

• Aprio Wealth Management LLC invested approximately $272,000 to acquire 230 shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the first quarter, as disclosed in their recent SEC filing.
• Significant increases in ownership stakes were observed from several institutional investors, with GAMMA Investing LLC raising its position by 131,246.3%, now holding shares valued at approximately $456 million.
• Mettler-Toledo's latest quarterly earnings report revealed $10.09 EPS, beating analyst expectations, and the company has set its FY 2025 guidance at 42.100-42.600 EPS.

Aprio Wealth Management LLC bought a new stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 230 shares of the medical instruments supplier's stock, valued at approximately $272,000.

Other institutional investors also recently modified their holdings of the company. WPG Advisers LLC bought a new stake in shares of Mettler-Toledo International in the first quarter valued at about $41,000. Zions Bancorporation National Association UT bought a new stake in Mettler-Toledo International during the first quarter worth about $43,000. Golden State Wealth Management LLC lifted its position in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after purchasing an additional 35 shares during the period. Menard Financial Group LLC bought a new stake in Mettler-Toledo International during the fourth quarter worth about $67,000. Finally, Blue Trust Inc. lifted its position in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after purchasing an additional 52 shares during the period. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Price Performance

NYSE MTD traded down $13.91 during trading hours on Wednesday, reaching $1,271.41. The company's stock had a trading volume of 15,268 shares, compared to its average volume of 169,479. The firm has a fifty day simple moving average of $1,255.58 and a 200-day simple moving average of $1,186.15. The stock has a market cap of $26.19 billion, a P/E ratio of 32.20, a P/E/G ratio of 3.94 and a beta of 1.37. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the firm earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on MTD. Bank of America upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Evercore ISI cut their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Barclays began coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 target price for the company. Finally, Citigroup boosted their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $1,311.11.

Insider Activity

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares of the company's stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 165 shares of the stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider directly owned 94 shares of the company's stock, valued at $123,012.16. This represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,827 shares of company stock valued at $2,371,208. Insiders own 0.77% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.